- Home
- AMBI vs ESPR Comparison
AMBI vs ESPR Comparison
Compare AMBI & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBI
- ESPR
- Stock Information
- Founded
- AMBI 1995
- ESPR 2008
- Country
- AMBI Brazil
- ESPR United States
- Employees
- AMBI N/A
- ESPR N/A
- Industry
- AMBI Environmental Services
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- AMBI Industrials
- ESPR Health Care
- Exchange
- AMBI Nasdaq
- ESPR Nasdaq
- Market Cap
- AMBI 265.0M
- ESPR 220.0M
- IPO Year
- AMBI N/A
- ESPR 2013
- Fundamental
- Price
- AMBI $4.95
- ESPR $2.17
- Analyst Decision
- AMBI
- ESPR Buy
- Analyst Count
- AMBI 0
- ESPR 6
- Target Price
- AMBI N/A
- ESPR $6.50
- AVG Volume (30 Days)
- AMBI 7.1K
- ESPR 5.2M
- Earning Date
- AMBI 01-01-0001
- ESPR 08-05-2025
- Dividend Yield
- AMBI N/A
- ESPR N/A
- EPS Growth
- AMBI N/A
- ESPR N/A
- EPS
- AMBI N/A
- ESPR N/A
- Revenue
- AMBI $525,221,427.00
- ESPR $268,125,000.00
- Revenue This Year
- AMBI N/A
- ESPR $6.10
- Revenue Next Year
- AMBI N/A
- ESPR N/A
- P/E Ratio
- AMBI N/A
- ESPR N/A
- Revenue Growth
- AMBI 25.42
- ESPR N/A
- 52 Week Low
- AMBI $3.70
- ESPR $0.69
- 52 Week High
- AMBI $8.20
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- AMBI 53.80
- ESPR 73.45
- Support Level
- AMBI $4.51
- ESPR $2.00
- Resistance Level
- AMBI $5.07
- ESPR $2.14
- Average True Range (ATR)
- AMBI 0.30
- ESPR 0.15
- MACD
- AMBI -0.00
- ESPR 0.02
- Stochastic Oscillator
- AMBI 51.16
- ESPR 95.08
About AMBI Ambipar Emergency Response
Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.